Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|July 31, 1986
Frameshift mutagenesis in Salmonella typhimurium by reversible DNA intercalators: effect of a UVR B mutationB René, C Auclair, C PaolettiMutation Research|May 1, 1988
Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coliB René, C Auclair, C PaolettiBiochimie|March 1, 1985
Use of a new DNA intercalating fluorescing probe for studies on the mechanism of frameshift mutagenesis in Salmonella typhimuriumB René, H Banoun, C Auclair, et al.Biochemistry|November 4, 1986
Relationship between cytostatic activity of oxazolopyridocarbazoles and accessibility of DNA intercalation sites in living bacteriaH Banoun, B René, C Auclair, et al.Mutation Research|November 1, 1988
Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificityB René, C Auclair, R P Fuchs, et al.Molecular Pharmacology|October 1, 1992
Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationshipP Fossé, B René, M Charra, et al.Molecular Pharmacology|August 1, 1994
Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitorsT Khélifa, M R Casabianca-Pignède, B René, et al.Bulletin Du Cancer|January 22, 1998
[Cytotoxicity and interaction of amsacrine derivatives with topoisomerase II: role of the 1' substitute on the aniline nucleus]B René, P Fossé, T Khélifa, et al.Bulletin Du Cancer|March 1, 1994
[In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship]P Fossé, M Charra, C Paoletti, et al.Nucleic Acids Research|June 11, 1991
Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivativeP Fossé, B René, M Le Bret, et al.Pageof 2